Digital mammography breast density estimates compared with standard-dose mammography.
Automated estimates of breast density made from synthetic digital mammograms is comparable to those from standard-dose mammograms, according to a study published in Radiology.
Researchers from the University of Pennsylvania in Philadelphia undertook a study to evaluate agreement between automated estimates of breast density made from standard-dose versus synthetic digital mammograms in a large cohort of women undergoing screening.
The study included 3,668 negative (Breast Imaging Reporting and Data System category 1 or 2) digital breast tomosynthesis (DBT) screening examinations consecutively performed over a four-month period. Both standard-dose and synthetic mammograms were available for analysis and were retrospectively analyzed.
The “For Presentation” standard-dose mammograms and synthetic images were analyzed by using a fully automated algorithm. Agreement between density estimates was assessed by using Pearson correlation, linear regression, and Bland-Altman analysis. Differences were evaluated by using the paired Student t test.
The results showed that breast percentage density (PD) estimates from synthetic and standard-dose mammograms were highly correlated (r = 0.92, P < .001), and the 95% Bland-Altman limits of agreement between PD estimates were −6.4% to 9.9%. The synthetic mammograms had PD estimates an average of 1.7% higher than standard-dose mammograms), with a larger disagreement by 1.56% in women with highly dense breast tissue.
The researchers concluded that fully automated estimates of breast density made from synthetic mammograms were generally comparable to those made from standard-dose mammograms. This finding could be important, they wrote. As clinicians strive to reduce radiation doses in screening mammograms, standard two-dimensional mammographic images are increasingly being replaced by synthetic mammograms in DBT screening.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.